Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
ONS-5010 for neovascular age-related macular degeneration	ONS-5010	Neovascular age-related macular degeneration	Ophthalmology	2022	View \| Download
Olaparib maintenance therapy for non-gBRCA mutated high-grade serous ovarian cancer after platinum-based chemotherapy	Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281)	Non-gBRCA mutated high-grade serous ovarian cancer	Female Reproductive Cancer	2022	View \| Download
Odevixibat for cholestatic liver disease in Alagille syndrome patients	Odevixibat (A4250)	Alagille syndrome	Genetic Disorders	2022	View \| Download
NPJ5008 for treating malignant hyperthermia	NPJ5008	Malignant hyperthermia	Genetic Disorders	2022	View \| Download
Nivolumab-ipilimumab for previously untreated advanced hepatocellular carcinoma	Nivolumab-ipilimumab	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2022	View \| Download
Nivolumab with ipilimumab for previously untreated locally advanced non-small-cell lung cancer	Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Nivolumab with ipilimumab adjuvant therapy for renal cell carcinoma	Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2022	View \| Download
Nivolumab with chemotherapy neoadjuvant followed by nivolumab adjuvant for treating early stage non-small-cell lung cancer	Chemotherapy , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Nivolumab in combination with chemotherapy for previously untreated unresectable or metastatic urothelial cancer	Chemotherapy , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Urothelial cancer	Urological Cancer	2022	View \| Download
Nivolumab adjuvant for treating for stage IIB/IIC resected melanoma	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Melanoma	Skin Cancer	2022	View \| Download